Nasdaq
NGEN
NervGen Pharma Corp.
- Health Care
- Canada
- 1 day
- +2.4%
- 1 month
- −14.4%
- 1 year
- −23.8%
$1.72 · Mkt cap $141M
At the 6 Aug 2026 close
Nasdaq
NervGen Pharma Corp.
$1.72 · Mkt cap $141M
At the 6 Aug 2026 close
NervGen Pharma Corp. trades under the ticker NGEN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $141M. The last closing price was $1.72, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −23.8%, and −14.4% over the past month. Returns are price returns and exclude dividends.
This page exists because NGEN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.